Keyphrases
Hepatitis B e Antigen (HBeAg)
100%
Liver-specific
100%
Circulating microRNA
100%
MicroRNA
88%
Healthy Controls
33%
Chronic Hepatitis B
33%
Specific Genes
22%
Severe Complications
11%
Quantitative PCR
11%
Plasma Samples
11%
High Risk
11%
Negative Control
11%
Hepatocytes
11%
Host Immune Response
11%
Functional Studies
11%
Bioinformatics Analysis
11%
Immunopathogenesis
11%
MiRNA Target
11%
Complex Interactions
11%
Virus
11%
Cirrhosis
11%
Plasma Parameters
11%
Hepatocellular Carcinoma
11%
Liver Damage
11%
Medicine and Dentistry
Hepatitis B(e) Antigen
100%
Circulating microRNA
100%
microRNA
81%
Chronic Hepatitis B
27%
Immune Response
9%
Virus
9%
Liver Injury
9%
Liver Cirrhosis
9%
Quantitative Reverse Transcription Polymerase Chain Reaction
9%
Immunopathogenesis
9%
Hepatocellular Carcinoma
9%
Hepatocyte
9%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis B(e) Antigen
100%
Circulating microRNA
100%
microRNA
81%
Chronic Hepatitis B
27%
Liver Cirrhosis
9%
Liver Injury
9%
Liver Cell Carcinoma
9%
Immunopathogenesis
9%
Immunology and Microbiology
Blood Plasma
100%
Hepatitis B(e) Antigen
100%
Hepatitis B
27%
Quantitative Reverse Transcription Polymerase Chain Reaction
9%
Virus
9%
Blood Level
9%
Immunopathogenesis
9%
Host Immune Response
9%
Bioinformatics
9%